Summary
Updated Aug 31, 2026
Paul J. Sekhri is Director of Apnimed, Inc. (APMD). 12 SEC Form 4 filings on record going back to 2024, most recently on 3 August 2026. Most recent open-market trade: bought $200K of APMD on 3 August 2026. Lifetime open-market purchases: $284K. Historical track record: 1/5 stars across 3 tracked purchases.
Recent Transactions
11Every recent SEC Form 4 transaction Paul J. Sekhri has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 0% |
| 90-day win rate | 100% |
| Avg 5-day return | -11.14% |
| Avg 30-day return | -11.41% |
| Avg 90-day return | +19.67% |
| Best 30-day return | -11.26% |
Trading Pattern
InsiderAlpha's records for Paul J. Sekhri go back to 2024: 12 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $71K (4 buys totaling $284K). The largest single buy on record is $200K of APMD in 2026. 3 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul J. Sekhri files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas D. Schwenger - $11.44M of VEEV open-market activity in the last 12 months
- Morningside Venture Investments Ltd - $5.00M of APMD open-market activity in the last 12 months
- Jonathan Faddis - $4.59M of VEEV open-market activity in the last 12 months
- Eleni Nitsa Zuppas - $1.84M of VEEV open-market activity in the last 12 months
- Priscilla Hung - $232K of VEEV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Paul J. Sekhri?
Paul J. Sekhri is a corporate insider, tracked as Director of Apnimed, Inc. (APMD). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Paul J. Sekhri submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Paul J. Sekhri been buying or selling stock?
Recorded transactions: 4 open-market purchases ($284K) and 0 open-market sales across all tracked filings.
How accurate is Paul J. Sekhri's historical track record?
Across 3 tracked purchases, Paul J. Sekhri averaged -11.4% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Paul J. Sekhri's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Paul J. Sekhri and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial